BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23243217)

  • 21. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.
    Migliore C; Martin V; Leoni VP; Restivo A; Atzori L; Petrelli A; Isella C; Zorcolo L; Sarotto I; Casula G; Comoglio PM; Columbano A; Giordano S
    Clin Cancer Res; 2012 Feb; 18(3):737-47. PubMed ID: 22179665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
    J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic biomarkers for metastatic colorectal cancer].
    Neumann JH
    Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
    Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S
    Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling.
    Ormanns S; Neumann J; Horst D; Kirchner T; Jung A
    Oncotarget; 2014 May; 5(10):2999-3011. PubMed ID: 24930890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
    Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
    Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A traditional Chinese medicine formula inhibits tumor growth in mice and regulates the miR-34b/c-Met/β-catenin pathway.
    Wang YP; Fu XQ; Yin CL; Chou JY; Liu YX; Bai JX; Chen YJ; Wu Y; Wu JY; Wang XQ; Liu B; Yu ZL
    J Ethnopharmacol; 2020 Oct; 260():113065. PubMed ID: 32505839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions.
    Siemens H; Jackstadt R; Hünten S; Kaller M; Menssen A; Götz U; Hermeking H
    Cell Cycle; 2011 Dec; 10(24):4256-71. PubMed ID: 22134354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.
    Gougelet A; Sartor C; Bachelot L; Godard C; Marchiol C; Renault G; Tores F; Nitschke P; Cavard C; Terris B; Perret C; Colnot S
    Gut; 2016 Jun; 65(6):1024-34. PubMed ID: 25792709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
    Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway.
    Chai WX; Sun LG; Dai FH; Shao HS; Zheng NG; Cai HY
    Pathol Res Pract; 2019 Oct; 215(10):152593. PubMed ID: 31471104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.
    Ji D; Chen Z; Li M; Zhan T; Yao Y; Zhang Z; Xi J; Yan L; Gu J
    Mol Cancer; 2014 Apr; 13():86. PubMed ID: 24755295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
    Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF
    J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.
    Mudduluru G; Ceppi P; Kumarswamy R; Scagliotti GV; Papotti M; Allgayer H
    Oncogene; 2011 Jun; 30(25):2888-99. PubMed ID: 21317930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
    Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
    Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
    Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
    Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.
    Torres-Ferreira J; Ramalho-Carvalho J; Gomez A; Menezes FD; Freitas R; Oliveira J; Antunes L; Bento MJ; Esteller M; Henrique R; Jerónimo C
    Mol Cancer; 2017 Jan; 16(1):26. PubMed ID: 28143614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.